# Remedy Robotics Secures $62M for AI Vascular Robot

> Remedy Robotics gets $62 million to build AI robot for stroke treatment.
- Title: Remedy Robotics Secures $62M for AI Vascular Robot | Shortify
- Summary: Remedy Robotics gets $62 million to build AI robot for stroke treatment. Remedy Robotics raised $62 million in Series B funding to advance its AI-enabled N1…
- Keywords: remedy robotics, series b, vascular intervention, neurovascular procedures, stroke treatment, fda approval, clinical trials, n1 system, endovascular procedures, AI Insider
- URL: https://shortify.news/AI_Insider/remedy-robotics-secures-62m-for-ai-vascular-robot
- Source: AI Insider — https://theaiinsider.tech/2026/11/17/remedy-robotics-raises-62m-in-series-b-funding-to-advance-ai-enabled-vascular-intervention-system
- Author: Greg Bock
- Published: 2026-11-17T09:36:16+00:00
- Read time: 1 min
- Topics: remedy robotics, series b, ai, vascular intervention, neurovascular procedures, stroke treatment, fda approval, clinical trials, n1 system, endovascular procedures, technology
## Funding Round Details
Remedy Robotics raised $62 million in Series B funding to advance its AI-enabled N1 robotic system toward clinical trials and potential FDA approval for neurovascular procedures including stroke treatment.
## Investors and Use of Funds
The DCVC-led round included UC Investments, Skip Capital, Hostplus and existing investors, with proceeds supporting a planned University of California clinical trial, prototype deployments and further development of autonomous capabilities.
## N1 System Capabilities
The N1 System is designed for on-site, remote and autonomous endovascular procedures but remains under development and is not approved for sale or clinical use in any jurisdiction.
## CEO's Statement
Co-founder and CEO Dr. David Bell said the funding will help speed up development and deployment of the N1 System to make specialized care more widely accessible, regardless of location.

> Endovascular intervention is the gold standard treatment for stroke and many cardiovascular emergencies, yet access remains limited to a small number of hospitals.
## What's Next
Remedy plans to conduct a pivotal clinical trial in partnership with the University of California, deploy prototype N1 Systems through clinical partners and continue developing autonomous capabilities.
## Technology and Impact
The N1 System uses machine learning to analyze medical images before procedures, simulate potential approaches and align three-dimensional and two-dimensional images in real time.
## Key takeaway

Remedy Robotics raised $62 million in Series B funding to advance its AI-enabled N1 robotic system toward clinical trials and potential FDA approval for neurovascular procedures including stroke treatment.

---

Summary: Shortify — https://shortify.news/AI_Insider/remedy-robotics-secures-62m-for-ai-vascular-robot
Reporting: AI Insider — https://theaiinsider.tech/2026/11/17/remedy-robotics-raises-62m-in-series-b-funding-to-advance-ai-enabled-vascular-intervention-system

When you use this summary, link the Shortify URL for the summary and credit the reporting to its newsroom.